Breathe Well Live Well
|
Dr. Stork talks Allergic Asthma
WISH To improve the awareness of allergic asthma and help your viewers better understand the disease, Dr. Travis Stork, host of the Emmy Award-winning daytime medical/talk show “The Doctors”, and Angel Waldron from the non-profit Asthma and Allergy … |
View full post on asthma – Google News
 TopNews Arab Emirates |
Allergic asthma remission with three year treatment: study
Outcome Magazine (blog) Asthma Airways Though there is no known cure for dust mite induced allergies or asthma, long-term relief may be within reach with a three year regiment of immunotherapy (allergy shots), according to a new study, published in the October issue of Annals … Relief from Allergic Asthma in Just Three Years Dust mite allergy treatment shortened by new research (Video) Now, there's long-term control of allergic asthma |
View full post on asthma – Google News
TopNews Arab Emirates |
Relief from Allergic Asthma in Just Three Years
Counsel & Heal Although there is no complete cure for childhood respiratory allergies, like dust mite induced allergies and asthma, researchers say that they now have a long term control for the allergy that can bring it under control just three years of allergy … Now, there's long-term control of allergic asthma Allergic Asthma Probably Needs Three-Year Treatment Administering immunotherapy for three years can reduce allergies, asthma in … |
View full post on asthma – Google News
 Khaleej Times |
Now, there's long-term control of allergic asthma
Khaleej Times “The recommended duration of immunotherapy for long-term effectiveness has been three to five years,” said Iwona Stelmach, from the American College of Allergy, Asthma and Immunology (ACAAI), who led the study. Khaleej Times “Our research shows that … Administering immunotherapy for three years can reduce allergies, asthma in … Doctors say to expect a long allergy season |
View full post on asthma – Google News
 Firstpost |
Now, long-term control of allergic asthma
Firstpost Washington: When children suffer from allergies and asthma induced by dust mites, finding relief seems an uphill task. Researchers now claim that three years of allergy shots would offer long-term control of allergic asthma. Allergic children react to … End your child's allergy suffering within three years Doctors say to expect a long allergy season |
View full post on asthma – Google News
|
When good cells go bad, allergic asthma can develop
Pittsburgh Post Gazette "We know that recurrent infections of RSV that require hospitalization in early life increase the risk for asthma in adult life," said Anuradha Ray, who along with Prabir Ray is a Pitt doctor of medicine and immunology. They are co-senior authors of … |
View full post on asthma – Google News
|
Rigel commences two Phase II allergic asthma and DLE studies
Equities.com Approximately 270 adults with allergic asthma will be randomized into the three arms of this Phase II clinical study of R343, called SITAR, or SYK Inhibition for Treatment of Asthma with R343, for eight weeks of treatment with either of two different … |
View full post on asthma – Google News
|
Asthmatic and Allergic Reactions to Mold
EmpowHer The presence of mold is much more than just unsightly. Mold in your house, school, place of business, or anywhere you spend any amount of time indoors, can lead to health problems. Molds can produce a multitude of unpleasantness. They can manufacture … |
View full post on asthma – Google News
 HealthCMI |
Acupuncture Controls Inflammatory Allergic Asthma
HealthCMI New research demonstrates that acupuncture reduces the allergic inflammatory process. Electro-acupuncture was investigated in a mouse hypersensitivity model that simulates human allergic asthma. In this controlled study, researchers used histopathology … |
View full post on asthma – Google News
| Related Articles |
Curcumin suppresses ovalbumin-induced allergic conjunctivitis.
Mol Vis. 2012;18:1966-72
Authors: Chung SH, Choi SH, Choi JA, Chuck RS, Joo CK
Abstract
PURPOSE: Allergic conjunctivitis (AC) from an allergen-driven T helper 2 (Th2) response is characterized by conjunctival eosinophilic infiltration. Because curcumin has shown anti-allergic activity in an asthma and contact dermatitis laboratory models, we examined whether administration of curcumin could affect the severity of AC and modify the immune response to ovalbumin (OVA) allergen in an experimental AC model.
METHODS: Mice were challenged with two doses of topical OVA via the conjunctival sac after systemic sensitization with OVA in aluminum hydroxide (ALUM). Curcumin was administered 1 h before OVA challenge. Several indicators for allergy such as serum immunoglubulin E (IgE) antibodies production, eosinophil infiltration into the conjunctiva and Th2 cytokine production were evaluated in mice with or without curcumin treatment.
RESULTS: Mice challenged with OVA via the conjunctival sac following systemic sensitization with OVA in ALUM had severe AC. Curcumin administration markedly suppressed IgE-mediated and eosinophil-dependent conjunctival inflammation. In addition, mice administered curcumin had less interleukin-4 (IL-4) and interleukin-5 (IL-5) (Th2 type cytokine) production in conjunctiva, spleen, and cervical lymph nodes than mice in the non-curcumin-administered group. OVA challenge resulted in activation of the production of inducible nitric oxide (iNOS), and curcumin treatment inhibited iNOS production in the conjunctiva.
CONCLUSIONS: We believe our findings are the first to demonstrate that curcumin treatment suppresses allergic conjunctival inflammation in an experimental AC model.
PMID: 22876123 [PubMed – in process]
View full post on pubmed: asthma